Patient Journeys who involved TKI-2 and TKI 3 Therapy for their Chronic myelogenous leukemia (CML) treatment

Background & Key Objectives:

To understand the attitude, behavior, motivations and opinions of patients regarding their disease and Chronic phase of CML treatment plan.

The client intend to gather inputs regarding:

Opinion of the patients current treatment and their past treatment. What treatments they have used for CML. Treatment impacts patient life Product and brand performance (based on effectiveness, safety, trust, access, ease of following dosage instructions)

Research Audience & Sample: CML Patients, We successfully completed the study based on the quotas set (n=30s from Indian market for CML TKI-2 & TKI-3 patients.

LOI: 50 minutes
Method: CATI
Region Covered: North, East and west regions.

Leave a Comment

Your email address will not be published. Required fields are marked *